Low SARS-CoV-2 antibody titers may be associated with poor clinical outcomes for patients with severe COVID-19.
Takita M, Yoshida T, Tsuchida T, Nakagama Y, Kido Y, Suzuki S, Imamura M, Kawahata K, Shimizu G, Yoshida H, Morikawa D, Kawaguchi T, Fujii S, Tsukuda J, Motohashi T, Fujitani S.
Takita M, et al. Among authors: yoshida h, yoshida t.
Sci Rep. 2022 Jun 1;12(1):9147. doi: 10.1038/s41598-022-12834-w.
Sci Rep. 2022.
PMID: 35650227
Free PMC article.